SANDRA TAYLOR: Open Payments
NPI 1609311513 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 47 payments from 7 companies in 2025. Trend: 2023 $568 · 2024 $286 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $220 |
| ABBVIE INC. | 13 | $180 |
| Alkermes, Inc. | 12 | $152 |
| Lundbeck LLC | 4 | $74 |
| Tris Pharma Inc | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, REXULTI, LYBALVI, ARISTADA, Dyanavel XR, ABILIFY MAINTENA, Qelbree.
Industry payments across KY — which companies pay providers there.
